ENaC Modulators and Renal Disease

Author(s): Diego Alvarez de la Rosa, Juan F. Navarro-Gonzalez, Teresa Giraldez

Journal Name: Current Molecular Pharmacology

Volume 6 , Issue 1 , 2013

Become EABM
Become Reviewer
Call for Editor


The epithelial sodium channel (ENaC) plays an essential role in transepithelial sodium reabsorption in the renal connecting tubule and collecting duct. Therefore, controlling ENaC activity is an important regulatory event in electrolyte and extracellular volume homeostasis, and thus in the control of blood pressure. Many independent signaling pathways converge on ENaC, although the most important for its physiological role is the enhancement of channel activity by the steroid hormone aldosterone. In this review, we briefly summarize current knowledge about ENaC regulation and the different chemical compounds available to directly or indirectly modify channel function. In addition, current and possible clinical uses of ENaC and aldosterone antagonists are highlighted.

Keywords: Aldosterone, amiloride, epithelial sodium channel, hypertension, mineralocorticoid receptor.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 30 May, 2013
Page: [35 - 43]
Pages: 9
DOI: 10.2174/1874467211306010005

Article Metrics

PDF: 88